Inventor · disambiguated record
Carlos Guzman
Also filed as: GUZMAN CARLOS · GUZMAN CARLOS A · GUZMAN CARLOS ALBERTO
16 granted patents·6 pending applications·73 citations·filing 1999–2023
90Inventor score
Files withEBENSEN THOMAS5GUZMAN CARLOS3HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH3UNIV ALBERTA3BIOTECHNOLOG FORSCHUNG GMBH2
Top patents by PatentIndex Score
22 records- 0189US9597391B2Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositionsEBENSEN THOMAS·Filed 2006·Granted Mar 21, 2017·24 cites·12 claims
- 0283US8397504B2Method and apparatus to recover and convert waste heat to mechanical energyGUZMAN CARLOS·Filed 2010·Granted Mar 19, 2013·9 cites·20 claims
- 0383US8053417B2Hexosylceramides as adjuvants and their uses in pharmaceutical compositionsHELMHOLTZ INFEKTIONSFORSCHUNG·Filed 2006·Granted Nov 8, 2011·4 cites·27 claims
- 0479US12042536B2Hepatitis C virus immunogenic compositions and methods of use thereofUNIV ALBERTA·Filed 2023·Granted Jul 23, 2024·0 cites·16 claims
- 0579US8119689B2Adjuvants on the basis of bisacyloxypropylcystene conjugates and derivatives and their uses in pharmaceutical compositionsEBENSEN THOMAS·Filed 2006·Granted Feb 21, 2012·6 cites·29 claims
- 0678US8468253B2Method and apparatus for multimedia collaboration using a social network systemGUZMAN CARLOS·Filed 2008·Granted Jun 18, 2013·8 cites·15 claims
- 0771US11576968B2Hepatitis C virus immunogenic compositions and methods of use thereofUNIV ALBERTA·Filed 2020·Granted Feb 14, 2023·0 cites·19 claims
- 0870US8257734B2PQS and its conjugates as adjuvants and their uses in pharmaceutical compositionsEBENSEN THOMAS·Filed 2006·Granted Sep 4, 2012·1 cites·13 claims
- 0967US8069236B2Flow control of events based on threshold, grace period, and event signatureAGRAHARAM SANJAY·Filed 2008·Granted Nov 29, 2011·7 cites·19 claims
- 1066US10881726B2Hepatitis C virus immunogenic compositions and methods of use thereofUNIV ALBERTA·Filed 2017·Granted Jan 5, 2021·0 cites·18 claims
- 1160US10905761B2Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinationsHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2013·Granted Feb 2, 2021·0 cites·11 claims
- 1257US7115269B2Attenuated Salmonella strain used as a vehicle for oral immunizationBIOTECHNOLOG FORSCHUNG GMBH·Filed 1999·Granted Oct 3, 2006·14 cites·15 claims
- 1352US2005276813A1Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinationsMUHLRADT PETER·Filed 2003·Application pending·0 cites
- 1451US8924480B2Method and apparatus for multimedia collaboration using a social network systemAT & T IP I LP·Filed 2013·Granted Dec 30, 2014·0 cites·20 claims
- 1551US8211463B2Use of glycolipids as adjuvantsEBENSEN THOMAS·Filed 2007·Granted Jul 3, 2012·0 cites·9 claims
- 1650US2022257752A1New use of cyclic dinucleotidesHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2020·Application pending·0 cites
- 1747US2012066139A1Methods, Systems, and Processes for Identifying Affected and Related Individuals During a CrisisGUZMAN CARLOS·Filed 2010·Application pending·0 cites
- 1840US10918733B2Lipopeptide- and lipoprotein-conjugates and its useEBENSEN THOMAS·Filed 2010·Granted Feb 16, 2021·0 cites·13 claims
- 1937US2021030865A1Method for determining vaccine efficacy in an individual and means thereforeHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2019·Application pending·0 cites
- 2036US9902406B2Commuter train and railway car exit ladder assembly and methods of storage and useRAILCAR PARTS MFG INC·Filed 2014·Granted Feb 27, 2018·0 cites·18 claims
- 2134US2002106376A1Therapeutic or prophylactic composition of fibronectin-binding protein 1 (SFBI) as adjuvantBIOTECHNOLOG FORSCHUNG GMBH·Filed 2002·Application pending·0 cites
- 2229US2016200233A1Safety Handle and Kit for Use on Public Transportation, Including the Methods of Use and InstallationRAILCAR PARTS MFG INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carlos Guzman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →